Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug 17;22(8):1060-1061.
doi: 10.1093/neuonc/noaa131.

Receptor discordance in breast cancer brain metastases: when knowledge is power

Sarah Sammons  1 , Amanda E D Van Swearingen  1 , Carey K Anders  1
Affiliations
Comment

Receptor discordance in breast cancer brain metastases: when knowledge is power

Sarah Sammons et al. Neuro Oncol. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Hulsbergen AFC, Claes A, Kavouridis VK, et al. . Subtype switching in breast cancer brain metastases: a multicenter analysis. Neuro Oncol. 2020;22(8):1173–1181. - PMC - PubMed
    1. Duchnowska R, Dziadziuszko R, Trojanowski T, et al. ; Polish Brain Metastasis Consortium Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain. Breast Cancer Res. 2012; 14(4):R119. - PMC - PubMed
    1. Jung J, Lee SH, Park M, et al. . Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis. J Neurooncol. 2018; 137(2):295–302. - PMC - PubMed
    1. Priedigkeit N, Hartmaier RJ, Chen Y, et al. . Intrinsic subtype switching and acquired ERBB2/HER2 amplifications and mutations in breast cancer brain metastases. JAMA Oncol. 2017; 3(5):666–671. - PMC - PubMed
    1. Fecci PE, Champion CD, Hoj J, et al. . The evolving modern management of brain metastasis. Clin Cancer Res. 2019; 25(22):6570–6580. - PMC - PubMed

Substances

Associated data